From Casetext: Smarter Legal Research

Novartis Pharmaceuticals Corp. v. Mylan Pharmaceuticals Inc.

United States Court of Appeals, Federal Circuit
Dec 6, 2011
440 F. App'x 924 (Fed. Cir. 2011)

Opinion

2011-1203

12-06-2011

NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellee, v. MYLAN PHARMACEUTICALS INC. AND MYLAN INC., Defendants-Appellants.


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the District of New Jersey in case no. 08-CV-5042, Judge Peter G. Sheridan.

ON MOTION


ORDER

Mylan Pharmaceuticals Inc. and Mylan Inc. move to dismiss their appeal.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The motion is granted. The appeal is dismissed.

(2) Each side shall bear its own costs.

FOR THE COURT

Jan Horbaly

Clerk

cc: Nicholas N. Kallas, Esq.

Larry L. Shatzer, Esq.

s21

Issued As A Mandate: DEC 06 2011


Summaries of

Novartis Pharmaceuticals Corp. v. Mylan Pharmaceuticals Inc.

United States Court of Appeals, Federal Circuit
Dec 6, 2011
440 F. App'x 924 (Fed. Cir. 2011)
Case details for

Novartis Pharmaceuticals Corp. v. Mylan Pharmaceuticals Inc.

Case Details

Full title:NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellee, v. MYLAN…

Court:United States Court of Appeals, Federal Circuit

Date published: Dec 6, 2011

Citations

440 F. App'x 924 (Fed. Cir. 2011)